celecoxib has been researched along with leptin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beales, IL; Ogunwobi, OO | 2 |
| Chan, PC; Chen, CH; Chiang, CF; Hsieh, PS; Jin, JS; Shih, KC | 1 |
3 other study(ies) available for celecoxib and leptin
| Article | Year |
|---|---|
Cyclo-oxygenase-independent inhibition of apoptosis and stimulation of proliferation by leptin in human colon cancer cells.
Topics: Apoptosis; Celecoxib; Cell Division; Cyclooxygenase 2; Cyclooxygenase Inhibitors; HT29 Cells; Humans; Leptin; Mitogen-Activated Protein Kinase Kinases; NF-kappa B; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Sulfonamides | 2007 |
COX-2-mediated inflammation in fat is crucial for obesity-linked insulin resistance and fatty liver.
Topics: Adipocytes; Adipogenesis; Adipose Tissue; Animals; Blood Glucose; Body Weight; Celecoxib; Cell Size; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprost; Disease Models, Animal; Fatty Liver; Insulin; Insulin Resistance; Leptin; Liver; Macrophages; Male; Membrane Proteins; Obesity; Panniculitis; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Time Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2009 |
Microsomal prostaglandin E synthase-1 inhibition blocks proliferation and enhances apoptosis in oesophageal adenocarcinoma cells without affecting endothelial prostacyclin production.
Topics: Adenocarcinoma; Apoptosis; Celecoxib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endothelial Cells; Epoprostenol; Esophageal Neoplasms; Humans; Intramolecular Oxidoreductases; Leptin; Prostaglandin-E Synthases; Pyrazoles; RNA, Small Interfering; Sulfonamides | 2010 |